Mapracorat Completed Phase 3 Trials for Cataracts / Inflammation / Surgery Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01591161 | Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | |
NCT01591655 | Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |